Ticker brief
SBFM SUNSHINE BIOPHARMA INC
Consumer, Non-cyclical · Pharmaceuticals
last close
$1.12
1 day
+0.0%
14 days
-14.5%
mkt cap
·
signals 14d
5
authors 14d
3
crowd 14d
+0.44
Sentiment — last 14 days
daily mean sentiment, 2026-08-19 → 2026-08-26 · now +0.40 (−1 bearish … +1 bullish)
Who spoke3
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Benzinga | C | +0.89 | 3 | +0.45 |
| @CrweWorld | C | · | 1 | +0.50 |
| @AccesswireNews | C | · | 1 | +0.35 |
Recent signals5of 5 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-26 | @Benzinga | +0.40 | Reports tumor-suppressing preclinical activity and planned combination testing for K1.1 mRNA. | — | tweet ↗ |
| 2026-08-26 | @AccesswireNews | +0.35 | Sunshine Biopharma reports in-vivo tumor suppression and progress on an mRNA cancer vaccine. | — | tweet ↗ |
| 2026-08-26 | @Benzinga | +0.45 | Reports preclinical tumor suppression and advancement of SBFM's mRNA cancer vaccine. | — | tweet ↗ |
| 2026-08-19 | @Benzinga | +0.50 | Reports Canadian approval of Sunshine Biopharma's generic Enalapril tablets. | — | tweet ↗ |
| 2026-08-19 | @CrweWorld | +0.50 | Sunshine Biopharma received Canadian regulatory approval for Enalapril. | — | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.